Merck
MRK
#55
Rank
A$396.48 B
Marketcap
A$158.73
Share price
1.78%
Change (1 day)
-0.43%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.82

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.93. In 2024 the company made an earnings per share (EPS) of A$9.73 an increase over its 2023 EPS that were of A$0.22.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$11.8221.5%
2024A$9.734308.46%
2023A$0.22-97.32%
2022A$8.2510.92%
2021A$7.4484.68%
2020A$4.03-27.2%
2019A$5.5363.44%
2018A$3.38151.11%
2017A$1.35-54.58%
2016A$2.9730.21%
2015A$2.28-61.99%
2014A$5.99180.51%
2013A$2.14-31.82%
2012A$3.136.62%
2011A$2.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.03 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.59-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$2.48-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.60 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$29.54 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$18.76 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.33-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.28-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.18-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.91-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel